Literature DB >> 18565423

Selenium status of the Swiss population: assessment and change over a decade.

Judith Burri1, Max Haldimann, Vincent Dudler.   

Abstract

A monitoring study of serum selenium concentration was carried out on healthy blood donors from different regions of Switzerland. With an overall mean serum concentration of 98 microg/L (n=1847), the selenium status of the healthy adults can be assessed as adequate. The lowest measured concentration of 62 microg/L denotes that the risk of a marginal selenium deficiency in the Swiss population is small. Compared to a similar study carried out in 1993, the status improved for both genders, although the increase is higher among women. It is noteworthy that the supplementation practice has increased during this period with ca. 2% of the population taking Se-micronutrients. No correlation between the age and the serum concentration is detected, even though the age-range was enlarged in this study to 18-68 years for the women and to 19-72 years for the men. The place of residence only marginally influences the selenium concentration, which implies a certain uniformity of the dietary habits between the various regions of the country.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18565423     DOI: 10.1016/j.jtemb.2007.11.002

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  13 in total

Review 1.  Selenium for preventing cancer.

Authors:  Marco Vinceti; Gabriele Dennert; Catherine M Crespi; Marcel Zwahlen; Maree Brinkman; Maurice P A Zeegers; Markus Horneber; Roberto D'Amico; Cinzia Del Giovane
Journal:  Cochrane Database Syst Rev       Date:  2014-03-30

Review 2.  Selenium for preventing cancer.

Authors:  Gabriele Dennert; Marcel Zwahlen; Maree Brinkman; Marco Vinceti; Maurice P A Zeegers; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

3.  Changing levels of selenium and zinc in cadmium-exposed workers: probable association with the intensity of inflammation.

Authors:  Vugar Ali Turksoy; Lutfiye Tutkun; Meside Gunduzoz; Ozgur Oztan; Serdar Deniz; Servet Birgin Iritas
Journal:  Mol Biol Rep       Date:  2019-07-30       Impact factor: 2.316

4.  Evaluation of Serum Selenium Status by Age and Gender: A Retrospective Observational Cohort Study in Western Romania.

Authors:  Teofana Otilia Bizerea-Moga; Laura Pitulice; Otilia Bizerea-Spiridon; Tudor Voicu Moga
Journal:  Nutrients       Date:  2021-04-28       Impact factor: 5.717

5.  The Level of Selenium and Oxidative Stress in Workers Chronically Exposed to Lead.

Authors:  Natalia Pawlas; Michał Dobrakowski; Aleksandra Kasperczyk; Agnieszka Kozłowska; Agnieszka Mikołajczyk; Sławomir Kasperczyk
Journal:  Biol Trace Elem Res       Date:  2015-07-17       Impact factor: 3.738

6.  Relatively high mortality risk in elderly Swedish subjects with low selenium status.

Authors:  U Alehagen; P Johansson; M Björnstedt; A Rosén; C Post; J Aaseth
Journal:  Eur J Clin Nutr       Date:  2015-06-24       Impact factor: 4.016

7.  Significant decrease of von Willebrand factor and plasminogen activator inhibitor-1 by providing supplementation with selenium and coenzyme Q10 to an elderly population with a low selenium status.

Authors:  Urban Alehagen; J Alexander; J Aaseth; A Larsson; T L Lindahl
Journal:  Eur J Nutr       Date:  2020-02-20       Impact factor: 5.614

Review 8.  Selenium for preventing cancer.

Authors:  Marco Vinceti; Tommaso Filippini; Cinzia Del Giovane; Gabriele Dennert; Marcel Zwahlen; Maree Brinkman; Maurice Pa Zeegers; Markus Horneber; Roberto D'Amico; Catherine M Crespi
Journal:  Cochrane Database Syst Rev       Date:  2018-01-29

9.  Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial.

Authors:  Urban Alehagen; Jan Alexander; Jan Aaseth
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

10.  Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly.

Authors:  Urban Alehagen; Jan Aaseth; Jan Alexander; Peter Johansson
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.